Prominent Players in the Romania Angina Market | Top Companies & Insights 2026

Prominent Players in the Romania Angina Market

Romania Angina Market is curated by a combination of major global players and domestic producers, each vying for market share through product innovation and promotion of sustainable practices. Major companies in the market include AstraZeneca, Pfizer, Zentiva, and Antibiotice SA.

Romania Angina Market Overview

According to 6Wresearch, the Romania angina market is poised for development, determined by its diverse applications across the healthcare sector, including cardiology, emergency medicine, and chronic disease management. The market is influenced by the rising demand for natural and patient-centric treatment methods, as consumers focus towards effective life-saving interventions in personal care and home-based recovery.

Generally, angina products are specialized medical tools designed to manage the symptoms and causes of chest pain resulting from reduced blood flow to the heart. These products appear as nitrate sprays, beta-blockers, calcium channel blockers, or advanced drug-eluting stents and are used extensively in clinical and homecare applications.

Competitive Landscape

The competitive landscape of the Romania angina industry is specified by the presence of numerous international players, local manufacturers, and emerging companies. Market leaders have a high market share on account of their longstanding presence in the pharmaceutical and medical device industries. These leaders invest heavily towards research and development (R&D) to create smart delivery systems and eco-friendly products to satisfy the consumer demand for improved patient compliance.

Below is a list of leading players operating in the Romania Angina Market:

1. AstraZeneca Romania

AstraZeneca is a dominant leader, with its portfolio of statins and antiplatelet therapies being widely utilized in cardiology departments.

2. Zentiva Romania

Zentiva provides essential fixed-dose combination therapies that form the backbone of chronic management for angina.

3. Antibiotice SA

Antibiotice SA is a major player in the cardiovascular segment, focusing on advanced calcium channel blockers and nitrate-based treatments.

4. Terapia SA (a Sun Pharma Company)

Terapia maintains a strong presence through its innovative beta-blockers and metabolic agents tailored for the aging population.

5. Servier Pharma

Servier Pharma is a key player in providing high-efficacy cardiovascular solutions and specialized circulatory system medicines.

6. Gedeon Richter Romania

Gedeon Richter focuses on its flagship ARB-based therapies and combination drugs designed to prevent ischemic heart disease complications.

7. Biofarm SA

Biofarm provides critical anti-anginal agents and is a leader in the R&D of novel circulatory system treatments.

8. Sanofi Romania

Sanofi specializes in high-quality intravenous and oral cardiovascular drugs and is active in distributing specialized heart disease therapies.

9. Viatris Romania

Viatris is a leading manufacturer and distributor that partners with global firms to bring specialized antiplatelet tools and anti-anginal medications.

10. Pfizer Romania

Pfizer is a prominent international distributor that provides a wide range of industry-standard calcium channel blockers and lipid-lowering therapies.

Prominent Players in the Romania Angina Market: FAQs